Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients [NA]
This clinical trial update notes the completion of a study examining social cognition in Multiple Sclerosis patients using morphological and…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS [NA]
The trial evaluated a self-managed tool called 'Imaginative Distention' for coping with fatigue, insomnia, and stress in people with multipl…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis [NA]
A completed clinical trial evaluated the effect of natalizumab (Tysabri) on sexual dysfunction in people with multiple sclerosis; results we…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Effects of the Cross-Training in Patients With Multiple Sclerosis [NA]
The clinical trial update indicates that the cross-training study in patients with Multiple Sclerosis has completed. No trial results are pr…
-
FDA approval · 2017-03-28FDA Approved: OCREVUS — Original Application (Genentech, Inc.)
FDA approved Ocrevus (ocrelizumab) in an original application from Genentech for the treatment of multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Developing and Testing a Comprehensive MS Spasticity Management Program [Phase 2]
Phase 2 update reporting completion and posting of results for a comprehensive spasticity management program in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis [Phase 3]
Phase 3 efficacy and safety results for prolonged-release dalfampridine (dalfampridine-ER) in people with multiple sclerosis have been poste…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Safety of RG2077 in Patients With Multiple Sclerosis [Phase 1]
Phase 1 safety update reporting on RG2077 in patients with multiple sclerosis, including relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases [NA]
A clinical trial comparing gadobutrol to gadopentetate dimeglumine or gadobenate dimeglumine before DCE-MRI in patients with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis [Phase 3]
Phase 3 study evaluating MD1003 for chronic visual loss related to optic neuritis in multiple sclerosis; current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of MD1003 in Spinal Progressive Multiple Sclerosis [Phase 3]
This document provides an update on the Phase 3 trial of MD1003 for spinal progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Long-term Follow-up of Fingolimod Phase II Study Patients [Phase 4]
Long-term follow-up results from fingolimod in a Phase II study for relapsing forms of multiple sclerosis have been reported (Phase 4 update…
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis [Phase 2]
Phase 2 study evaluating white blood cell counts in cerebrospinal fluid and blood of patients with relapsing multiple sclerosis. The trial s…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial evaluating the safety of Xeomin (incobotulinumtoxinA) for lower limb spasticity in patients with multiple sclerosis h…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers [Phase 4]
Phase 4 study investigating pharmacokinetics of dimethyl fumarate and its effects on exploratory biomarkers in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating oral prolonged-release dalfampridine (BIIB041) for safety and efficacy in Japanese participants with multiple scler…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Phase 4]
Phase 4 trial comparing fingolimod to interferon beta-1b in adults with multiple sclerosis to assess cognitive symptoms; results were posted…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
This completed clinical trial evaluated strategies to manage flu-like symptoms in multiple sclerosis patients beginning treatment with Betaf…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis [NA]
This document reports the completion of a randomized trial comparing two formal group programs for multiple sclerosis, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [NA]
Clinical trial update examining whether aerobic exercise reduces side effects of interferon beta-1b therapy in people with multiple sclerosi…
-
FDA approval · 2017-03-03FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic Tizanidine Hydrochloride from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy [NA]
This clinical trial update reports the completion of a study evaluating the effects of meditation on outcomes in people with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Lido Workset Study
The Lido Workset Study (NCT00710645) for multiple sclerosis has completed; it was sponsored by the University of California, Davis.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples
A completed clinical trial evaluating nanotechnology-based approaches for multiple sclerosis using respiratory samples.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: FlexToBa for People With Multiple Sclerosis [NA]
This clinical trial update reports on the completion of the FlexToBa study in people with multiple sclerosis. The status indicates the trial…